Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs currently on the market. Its double-digit growth makes it a standout segment within the general anti-infective therapeutic class. You should be maximizing your opportunities in this market. The opportunities for success are there now, you should capitalize on them immediately.
The key driver of the market is the rapid development of resistance to existing therapies by the evolving viruses. The constant need to update the pipeline fuels your investigative and commercial interest in this market so you must act on this today. This report - Global Antivirals Market, 2008-2023 - analyses the global antiviral market comprehensively, outlining where you should aim your future developments to guarantee success. The analyses tackle different aspects of the market, including the leading therapeutic classes, leading antiviral products, key industrial players as partners and financial prospects and opportunities. The report also delivers in-depth predictions concerning how the market will develop from present until 2023.
Global Antivirals Market, 2008-2023 examines the market for antivirals critically, through comprehensive primary and secondary research. In addition to consultation with experts in the industry, this research involved a detailed study of policy documents, industrial reports and relevant news. Essentially, visiongain also applied unique in-house techniques such as our developed financial forecasting, SWOT analyses and qualitative projections which are unavailable elsewhere. The result is a comprehensive market-focused study with detailed financial analyses and uniquely informed opinion on the future of the antivirals market.
In particular, our new Global Antivirals Market 2008-2023 report concentrates on the following essential aspects of that market:
Antiviral drugs assessment and opportunities
Key industrial players in the global antivirals market
Forecasts of global antivirals market from 2008-2023, including in-house developed forecasts of the leading therapeutic agents
Forecasts for the antiviral therapies in the seven leading developed pharmaceutical country markets and two leading developing markets
Drivers and opportunities in the global antivirals market
Restraints and threats in the global antivirals market
Key opinion from relevant experts - full interview transcripts are included with the report (unavailable anywhere else)
Coverage of pipeline developments in the antivirals market, with discussion of trends from the present onwards
Why you should buy this report :
To receive a comprehensive analysis of the prospects for the antivirals industry from 2008-2023, including sales forecasts, major growth areas and most exciting pipeline developments
To discover predicted revenues, growth rates and other key metrics in the global antivirals market from 2008-2023, with leading brands and principal market segments covered
To determine the forces that influence the global antivirals market:
Drivers and restraints on that market
Competition
Strengths, weaknesses, opportunities and threats.
To find out where the global antivirals market is heading from 2008 onwards - both technologically and commercially
The information contained in this report is not available in any other source and is essential reading for you and your colleagues. By ordering and reading this report you can gain market advantage on your competitors today. When aligned with your in-house findings we are confident you will continue to succeed over the next 15 years.
